Theratechnologies INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Nantahala Capital Management and its managing members have reported a 0.00% beneficial ownership in Theratechnologies Inc. as of September 30, 2025, indicating a full divestment.
NASDAQ
Summer Road LLC, a Delaware family office, has reported a 5.84% beneficial ownership stake in Theratechnologies Inc., holding 2,683,591 common shares.
NASDAQ
Morgan Stanley has reduced its beneficial ownership in Theratechnologies Inc. to 1.9%, falling below the 5% reporting threshold.
NASDAQ
AIGH Capital Management LLC and Orin Hirschman have filed an amendment to their Schedule 13G, disclosing a beneficial ownership of 3.4% of Theratechnologies, Inc.'s common stock as of June 30, 2025.
NASDAQ
Morgan Stanley has filed an amended Schedule 13G, revealing a 5.0% beneficial ownership stake in Theratechnologies Inc. as of December 31, 2024.
NASDAQ
AIGH Capital Management LLC and its managing member, Orin Hirschman, have disclosed a 6.1% beneficial ownership stake in Theratechnologies, Inc. common stock.